Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials

Bellinda L. King-Kallimanis; Upal Basu-Roy; Sandra Nolte

doi:10.1001/jamaoncol.2022.3521

Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials

Bellinda L. King-Kallimanis
, Upal Basu-Roy
, Sandra Nolte

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	1517
Number of pages	1
Journal	JAMA Oncology
Volume	8
Issue number	10
DOIs	https://doi.org/10.1001/jamaoncol.2022.3521
Publication status	Published - Oct 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jamaoncol.2022.3521

Cite this

@article{be74e875e8fb4c2e8fd050d8d7ff6740,

title = "Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials",

author = "King-Kallimanis, \{Bellinda L.\} and Upal Basu-Roy and Sandra Nolte",

year = "2022",

month = oct,

doi = "10.1001/jamaoncol.2022.3521",

language = "English",

volume = "8",

pages = "1517",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association (AMA)",

number = "10",

}

TY - JOUR

T1 - Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials

AU - King-Kallimanis, Bellinda L.

AU - Basu-Roy, Upal

AU - Nolte, Sandra

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85137488647

U2 - 10.1001/jamaoncol.2022.3521

DO - 10.1001/jamaoncol.2022.3521

M3 - Letter

C2 - 36006651

AN - SCOPUS:85137488647

SN - 2374-2437

VL - 8

SP - 1517

JO - JAMA Oncology

JF - JAMA Oncology

IS - 10

ER -

Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials

UN SDGs

Access to Document

Other files and links

Cite this